Sunday - December 22, 2024

Oxabicycloheptanes for Modulation of Immune Response

2024-12-17

ALEXANDRIA, Virginia, Dec. 17 -- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES, Bethesda, Maryland has been assigned a patent (No. US 12168008 B2, initially filed Dec. 8, 2017) developed by five inventors John S. Kovach, Pasadena, California; Zhengping Zhuang, Bethesda, Maryland; Sze Chun Winson Ho, Bethesda, Maryland; Herui Wang, Bethesda, Maryland; and Rongze Lu, Sunnyvale, California, for "Oxabicycloheptanes for modulation of immune res . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Oxabicycloheptanes for Modulation of Immune Response

Information Request Form

Copyright Targeted News Service 2024